Sep 05 1 Exciting News! CRADA with Retrophin, NCATS and NGLY1.org By NGLY1.org | Media, NGLY1 Deficiency, NGLY1.org, Research and Science | No Comments SAN DIEGO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ:RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes...Read More
Recent Comments